Biospecifics Technologies Corp (BSTC.OQ)
BSTC.OQ on NASDAQ Stock Exchange Global Market
57.87USD
3:05pm EDT
57.87USD
3:05pm EDT
Change (% chg)
$0.13 (+0.23%)
$0.13 (+0.23%)
Prev Close
$57.74
$57.74
Open
$57.51
$57.51
Day's High
$57.88
$57.88
Day's Low
$56.81
$56.81
Volume
11,494
11,494
Avg. Vol
9,833
9,833
52-wk High
$62.45
$62.45
52-wk Low
$38.12
$38.12
About
BioSpecifics Technologies Corp. is a biopharmaceutical company involved in the development of an injectable collagenase clostridium histolyticum for multiple indications. The Company has a development and license agreement with Endo Global Ventures, a Bermuda unlimited liability company (Endo Global Ventures), an affiliate of... (more)
Overall
| Beta: | 1.64 |
| Market Cap(Mil.): | $421.21 |
| Shares Outstanding(Mil.): | 7.29 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| BSTC.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 28.64 | 108.45 | 32.71 |
| EPS (TTM): | 2.02 | -- | -- |
| ROI: | 19.06 | 1.54 | 12.72 |
| ROE: | 19.78 | 0.30 | 14.84 |
BRIEF-Biospecifics Technologies Reports Q1 Earnings Per Share $0.54
* BIOSPECIFICS TECHNOLOGIES CORP. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS
Competitors
| Price | Chg | |
|---|---|---|
| Johnson & Johnson (JNJ.N) | $142.76 | +0.78 |
| Novartis AG (NOVN.S) | CHF81.88 | -0.06 |
| Pfizer Inc. (PFE.N) | $44.05 | +0.30 |
| Roche Holding Ltd. (ROG.S) | CHF235.15 | +0.10 |
| Roche Holding Ltd. (RO.S) | CHF235.40 | -1.20 |
| Merck & Co., Inc. (MRK.N) | $71.29 | +0.51 |
| Bayer AG (BAYGn.DE) | €76.52 | +0.70 |
| Bayer AG (BAYE.F) | -- | -- |
| Sanofi SA (SASY.PA) | €74.50 | -0.17 |
| GlaxoSmithKline plc (GSK.L) | 1,531.40 | +45.60 |
Estimates